ATOSSA THERAPEUTICS, INC. (ATOS) AI Dilution Summary

Cash was $26,094,000 at 2026-06-30, against estimated monthly burn of $3,214,667. The company's funding channel is an active ATM program with Rodman & Renshaw LLC, authorised to $50,000,000. It had sold 4,300 shares since the program began through 2026-06-30, and sales after 2026-06-30 are not yet reported.